Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immune Profiling for Cancer Immunotherapy Response

NCT06116032 is registered in ClinicalTrials.gov with Dartmouth-Hitchcock Medical Center as lead sponsor.

NCT NCT06116032
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06116032 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immune Profiling for Cancer Immunotherapy Response
Lead sponsor
Dartmouth-Hitchcock Medical Center
Phase
Observational
Overall status
Recruiting
Start date
October 3, 2022
Completion date
January 1, 2029
Enrollment
1,500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

blood cancer, cancer, hematologic malignancy, tumor, solid